
Dutch start-up OncoLize has closed a US$ 1.7 million seed investment round to extend their preclinical success with a localized drug delivery system to treat Pancreatic- and Lung cancer. The round was led by corner-stone investors Libertatis Ergo Holding (www.libertatisergo.com)…






